Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature

Peritoneal carcinomatosis is rare in prostate cancer especially in the absence of skeletal or other visceral metastases. We report a case of hormone refractory adenocarcinoma prostate presenting with only peritoneal metastases and massive malignant ascites. Palliation with docetaxel based cytotoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedict, Samuel P., Ahuja, Manish, Mammen, Kim J.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938557/
https://www.ncbi.nlm.nih.gov/pubmed/20877611
http://dx.doi.org/10.4103/0970-1591.65405
_version_ 1782186644762263552
author Benedict, Samuel P.
Ahuja, Manish
Mammen, Kim J.
author_facet Benedict, Samuel P.
Ahuja, Manish
Mammen, Kim J.
author_sort Benedict, Samuel P.
collection PubMed
description Peritoneal carcinomatosis is rare in prostate cancer especially in the absence of skeletal or other visceral metastases. We report a case of hormone refractory adenocarcinoma prostate presenting with only peritoneal metastases and massive malignant ascites. Palliation with docetaxel based cytotoxic chemotherapy resulted in clinical improvement of refractory ascites decreasing respiratory embarrassment and thereby improving the quality of life.
format Text
id pubmed-2938557
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29385572010-09-28 Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature Benedict, Samuel P. Ahuja, Manish Mammen, Kim J. Indian J Urol Case Report Peritoneal carcinomatosis is rare in prostate cancer especially in the absence of skeletal or other visceral metastases. We report a case of hormone refractory adenocarcinoma prostate presenting with only peritoneal metastases and massive malignant ascites. Palliation with docetaxel based cytotoxic chemotherapy resulted in clinical improvement of refractory ascites decreasing respiratory embarrassment and thereby improving the quality of life. Medknow Publications 2010 /pmc/articles/PMC2938557/ /pubmed/20877611 http://dx.doi.org/10.4103/0970-1591.65405 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Benedict, Samuel P.
Ahuja, Manish
Mammen, Kim J.
Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title_full Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title_fullStr Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title_full_unstemmed Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title_short Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature
title_sort hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: a case report and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938557/
https://www.ncbi.nlm.nih.gov/pubmed/20877611
http://dx.doi.org/10.4103/0970-1591.65405
work_keys_str_mv AT benedictsamuelp hormonerefractorycarcinomaprostatewithperitonealmetastasesandmalignantasciteswithoutskeletalinvolvementacasereportandreviewofliterature
AT ahujamanish hormonerefractorycarcinomaprostatewithperitonealmetastasesandmalignantasciteswithoutskeletalinvolvementacasereportandreviewofliterature
AT mammenkimj hormonerefractorycarcinomaprostatewithperitonealmetastasesandmalignantasciteswithoutskeletalinvolvementacasereportandreviewofliterature

Ejemplares similares